Latest filing published 20 Jun 2025 for Immunic, INC., €10k.
Filing timeline
BuySaleInsider track record
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Daniel Vitt: trading record in brief
Daniel Vitt (chief executive) discloses dealings in Immunic, Inc. to SEC (Form 4). In total, 8 filings cover trades dated from 20 July 2020 to 4 June 2025.
Market trades split into 6 purchases (€70k) and 2 sales (€81k). Sales outweigh purchases by €10k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2025, the count stands at 2 purchases and no sales.
Half of the purchases are above €10k and half below. 4 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
Most recently, on 20 June 2025, the filings show an open-market purchase worth €10k in Immunic, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Daniel Vitt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares@ US$0.7714.4% of flowCommon StockSEC:0001193805-25-000923:0Canonical exit: 2 Sept 2025 (T+90)
- 15,000 shares@ US$0.7716.8% of flowCommon StockSEC:0001193805-25-000821:0Canonical exit: 2 Sept 2025 (T+90)
- 14,000 shares@ US$1.309529.1% of flowCommon StockSEC:0001193805-24-000282:0Canonical exit: 26 May 2024 (T+90)
- 8,000 shares@ US$1.349918.1% of flowCommon StockSEC:0001193805-22-001602:0Canonical exit: 20 Feb 2023 (T+90)
- 5,000 shares@ US$3.099923.9% of flowCommon StockSEC:0001193805-22-000919:0Canonical exit: 1 Sept 2022 (T+90)
- 1,000 shares@ US$9.6013.6% of flowCommon StockSEC:0001193805-21-001161:0Canonical exit: 8 Nov 2021 (T+90)
6 of 6 declarations